股票 › SUPN
速百纳斯制药 SUPN
美股市值排名 #2936
$26.16 −$0.58 (-2.17%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $26.16 0.00%
开盘$26.58
昨收$26.74
当日区间$25.92 – $27.08
成交量5.91M
市值$1.52B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例104.5%-0.23 个百分点，较上季度
持仓机构数396-3 ，较上季度
内部人近期交易20次买入 / 26次卖出净卖出
空头持仓比例6.95% 占流通股回补天数 4.9 · 截至 15 Oct 2026
卖空成交量占比13.6%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$549.0K（9个净流入日，11个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有37.9%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从8.30%降至6.95%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +913,150 | 2.0% |
| Armistice Capital LLC | Hedge Fund | 2026/Q3 | +750,854 | 4.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +552,792 | 16.1% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +537,239 | 6.6% |
| Soleus Capital Management, L.P. | Hedge Fund | 2026/Q3 | +520,000 | 0.9% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +423,968 | 1.6% |
| Macquarie Investment Management Business Trust | Mutual Fund | 2026/Q3 | +341,127 | 4.1% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +283,036 | 1.2% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +259,280 | 1.2% |
| Schroder Investment Management Limited | Mutual Fund | 2026/Q3 | +191,941 | 0.6% |
| abrdn plc | Mutual Fund | 2026/Q3 | +177,645 | 0.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +171,701 | 4.2% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +145,218 | 1.3% |
| Stephens Investment Management Group, LLC | Mutual Fund | 2026/Q3 | +134,490 | 2.6% |
| Hillsdale Investment Management Inc. | Mutual Fund | 2026/Q3 | +103,680 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 11 Aug 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Derivative Exercise and Sale | -12,642 | $46.57 | 2,216,451 |
| 11 Aug 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Derivative Exercise and Retained | +17,207 | – | 2,216,451 |
| 11 Aug 2026 | Timothy Dec | Senior Vice President | Derivative Exercise and Sale | -604 | $46.57 | 9,129 |
| 11 Aug 2026 | Timothy Dec | Senior Vice President | Derivative Exercise and Retained | +646 | – | 9,129 |
| 11 Aug 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Derivative Exercise and Sale | -1,158 | $46.57 | 18,637 |
| 11 Aug 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Derivative Exercise and Retained | +1,342 | – | 18,637 |
| 11 Aug 2026 | Jonathan Rubin | Senior VP of Research & Development and Chief Medical Officer | Derivative Exercise and Sale | -363 | $46.57 | 13,979 |
| 11 Aug 2026 | Jonathan Rubin | Senior VP of Research & Development and Chief Medical Officer | Derivative Exercise and Retained | +387 | – | 13,979 |
| 11 Aug 2026 | Frank Mottola | Senior VP & Chief Technology Operations Officer | Derivative Exercise and Sale | -797 | $46.57 | 19,544 |
| 11 Aug 2026 | Frank Mottola | Senior VP & Chief Technology Operations Officer | Derivative Exercise and Retained | +853 | – | 19,544 |
| 28 Jul 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Other Derivative Acquisition | +29,849 | – | 29,849 |
| 28 Jul 2026 | Timothy Dec | Senior Vice President | Other Derivative Acquisition | +1,250 | – | 1,250 |
| 28 Jul 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Other Derivative Acquisition | +2,500 | – | 2,500 |
| 28 Jul 2026 | Jonathan Rubin | Senior VP of Research & Development and Chief Medical Officer | Other Derivative Acquisition | +750 | – | 750 |
| 28 Jul 2026 | Frank Mottola | Senior VP & Chief Technology Operations Officer | Other Derivative Acquisition | +1,650 | – | 1,650 |
| 17 Mar 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Derivative Exercise and Sale | -107,250 | $50.73 | 17,044 |
| 16 Mar 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Intent to Sell (Form 144) | -57,250 | $50.21 | – |
| 15 Mar 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Intent to Sell (Form 144) | -50,000 | $49.91 | – |
| 12 Mar 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Other Acquisition | +12,500 | – | 2,199,244 |
| 12 Mar 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Other Disposition | -12,500 | – | 2,199,244 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 4,043,677 | 6.9% | 4.9 |
| 30 Sep 2026 | 4,985,929 | 8.6% | 7.4 |
| 15 Sep 2026 | 4,989,421 | 8.6% | 8.7 |
| 31 Aug 2026 | 4,671,860 | 8.0% | 8.3 |
| 14 Aug 2026 | 4,147,629 | 7.1% | 2.8 |
| 31 Jul 2026 | 4,816,923 | 8.3% | 9.5 |
暂无评论——快来第一个聊聊 SUPN。